Clinical Trial Detail

NCT ID NCT02646319
Title Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Mayo Clinic
Indications

cervical squamous cell carcinoma

renal cell carcinoma

breast cancer

uterine cancer

Advanced Solid Tumor

urinary bladder cancer

head and neck cancer

ovarian cancer

endometrial cancer

Therapies

Nab-Rapamycin

Age Groups: senior adult

Additional content available in CKB BOOST